The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Case Study Suggests Milk Thistle Is Potent Against Hep C

Back to News Homepage

Next

AbbVie to Add Liver Warning on Hep C Drugs

Coverage Restrictions for Hepatitis C Drugs

Print this page

Find out three common policies that insurance companies generally use to limit access for Hepatitis C patients to direct-acting antivirals.

How insurance providers deny hepatitis C patients lifesaving drugs

October 16, 2015

by Sony Salzman

Doctors say up to 80 percent of patients are denied expensive but effective drugs like Harvoni.

Amber Rojas was almost eight months pregnant when she learned she had hepatitis C. After her daughter was born on Dec. 23, 2014, Rojas had hoped to start treatment with a newly approved, highly effective drug called Harvoni.

Continue reading this entire article:
http://america.aljazeera.com/articles/2015/10/16/insurance-providers-deny-hepatitis-drugs.html

5 Comments
Share
Share

Previous

Case Study Suggests Milk Thistle Is Potent Against Hep C

Back to News Homepage

Next

AbbVie to Add Liver Warning on Hep C Drugs

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.